|
業務類別
|
Biotechnology |
|
業務概覽
|
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma. |
| 公司地址
| 3115 Merryfield Row, Suite 120, San Diego, CA, USA, 92121 |
| 電話號碼
| +1 858 684-1300 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.gossamerbio.com |
| 員工數量
| 145 |
| Mr. Faheem Hasnain |
Chairman of the Board, President and Chief Executive Officer |
美元 628.17K |
29/04/2025 |
| Mr. Christian Waage |
Executive Vice President, Technical Operations and Administration |
-- |
29/04/2025 |
| Mr. Bryan Giraudo |
Chief Operating Officer, Chief Financial Officer and Principal Accounting officer |
美元 502.65K |
29/04/2025 |
| Mr. Bob Smith |
Chief Commercial Officer |
-- |
29/04/2025 |
| Ms. Caryn Peterson |
Executive Vice President, Regulatory Affairs |
-- |
29/04/2025 |
| Dr. Richard Aranda, M.D. |
Chief Medical Officer |
美元 481.09K |
29/04/2025 |
|
|
| Mr. Faheem Hasnain |
Chairman of the Board, President and Chief Executive Officer |
29/04/2025 |
| Mr. Russell J. Cox |
Independent Director |
29/04/2025 |
| Dr. Thomas O. Daniel, M.D. |
Lead Independent Director |
29/04/2025 |
| Ms. Skye Drynan |
Independent Director |
29/04/2025 |
| Dr. Steven Nathan, M.D. |
Independent Director |
29/04/2025 |
| Dr. John D. Quisel, J.D.,PhD |
Independent Director |
29/04/2025 |
| Dr. Sandra Milligan, J.D.,M.D. |
Independent Director |
29/04/2025 |
|
|
|
|
